ArticleCancers2019

Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial.

Malgorzata Banys-Paluchowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.